222 related articles for article (PubMed ID: 27061353)
1. The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux.
Karakus SC; User İR; Kılıc BD; Akçaer V; Ceylan H; Ozokutan BH
J Pediatr Surg; 2016 Sep; 51(9):1496-500. PubMed ID: 27061353
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
Kocaoglu C
J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
[TBL] [Abstract][Full Text] [Related]
4. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
5. A review of novel STING bulking agents.
Starmer B; McAndrew F; Corbett H
J Pediatr Urol; 2019 Oct; 15(5):484-490. PubMed ID: 31591047
[TBL] [Abstract][Full Text] [Related]
6. Vantris vs. deflux for treatment of paediatric vesicoureteral reflux: Efficacy and obstruction risk.
Renaux-Petel M; Grynberg L; Lubet A; Comte D; Liard-Zmuda A
Fr J Urol; 2024 Mar; 34(2):102585. PubMed ID: 38717460
[TBL] [Abstract][Full Text] [Related]
7. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.
Alizadeh F; Omidi I; Haghdani S; Hatef Khorrami M; Izadpanahi MH; Mohammadi Sichani M
Urol J; 2019 May; 16(2):174-179. PubMed ID: 30178456
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).
Warchol S; Krzemien G; Szmigielska A; Bombinski P; Brzewski M; Dudek-Warchol T
J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Subureteral Endoscopic Injection of Dextranomer/Hyaluronic Acid and Lich-Gregoir Ureteral Reimplantation in the Treatment of Pediatric Primary Vesicoureteral Reflux: A Prospective Randomized Study.
Salih EM; Eldamanhory H; Selmy GI; Galal HA
J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):719-723. PubMed ID: 33751917
[No Abstract] [Full Text] [Related]
10. Comparison of polyacrylate polyalcohol copolymer (PPC) and dextranomer/hyaluronic acid (Dx/HA) for treatment of vesicoureteral reflux. A systematic review and meta-analysis.
Gholami B; Gholami S; Khodaei B; Sharifiaghdas F
J Pediatr Urol; 2022 Oct; 18(5):664-673. PubMed ID: 36153243
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: Comparison of Dexell and Vantris.
Doğan AB; Özkan KU; Güler AG; Karakaya AE
Actas Urol Esp (Engl Ed); 2021 Oct; 45(8):545-551. PubMed ID: 34526255
[TBL] [Abstract][Full Text] [Related]
12. Dextranomer-Hyaluronic Acid and Polyacrylate-Polyalcohol Copolymer are Equally Efficient for Endoscopic Treatment of Vesicoureteral Reflux in Children.
Bele U; Bratus D
Urol J; 2019 Aug; 16(4):361-365. PubMed ID: 30318569
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
Garcia-Aparicio L; Martin-Sole O; Capdevila-Vilaro B; Perez-Bertolez S
World J Urol; 2023 Oct; 41(10):2855-2859. PubMed ID: 37584692
[TBL] [Abstract][Full Text] [Related]
14. A systematic review & meta-analysis comparing outcomes of endoscopic treatment of primary vesico ureteric reflux in children with polyacrylate poly alcohol copolymer versus dextranomer hyaluranic acid.
Babu R; Chandrasekharam VVS
J Pediatr Surg; 2022 Nov; 57(11):683-689. PubMed ID: 35197197
[TBL] [Abstract][Full Text] [Related]
15. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults.
Turk A; Selimoglu A; Demir K; Celik O; Saglam E; Tarhan F
Int Braz J Urol; 2014; 40(3):379-83. PubMed ID: 25010304
[TBL] [Abstract][Full Text] [Related]
17. Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?
Friedmacher F; Puri P
Curr Urol Rep; 2019 Jul; 20(9):49. PubMed ID: 31289951
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
[TBL] [Abstract][Full Text] [Related]
19. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
Cloutier J; Blais AS; Moore K; Bolduc S
J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
[TBL] [Abstract][Full Text] [Related]
20. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
Chertin B; Mele E; Kocherov S; Zilber S; Gerocarni Nappo S; Capozza N
J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
